Brian R. Stanton

Array ( [id] => 3872536 [patent_doc_number] => 05824543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Method for expression and isolation of biologically active molecules in urine using a mouse uroplakin-II promoter' [patent_app_type] => 1 [patent_app_number] => 8/464961 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 3608 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824543.pdf [firstpage_image] =>[orig_patent_app_number] => 464961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620600 [patent_doc_number] => 05593865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes' [patent_app_type] => 1 [patent_app_number] => 8/457845 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8181 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593865.pdf [firstpage_image] =>[orig_patent_app_number] => 457845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1445874 [patent_doc_number] => 06368572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Use of hematopoietic deficient cell transplanted chimeric nonhuman mammals as human bacterial toxin shock models' [patent_app_type] => B1 [patent_app_number] => 08/452492 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4819 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368572.pdf [firstpage_image] =>[orig_patent_app_number] => 08452492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587030 [patent_doc_number] => 05550055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Recombinant DNA-produced T11 and fragments thereof' [patent_app_type] => 1 [patent_app_number] => 8/449199 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4504 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550055.pdf [firstpage_image] =>[orig_patent_app_number] => 449199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3744226 [patent_doc_number] => 05716817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Transgenic non-human mammals that express human BSSL/CEL' [patent_app_type] => 1 [patent_app_number] => 8/442806 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 13845 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716817.pdf [firstpage_image] =>[orig_patent_app_number] => 442806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881486 [patent_doc_number] => 05728915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Transgenic mice which express simian SV 40 T-antigen under control of the retinoblastoma gene promoter' [patent_app_type] => 1 [patent_app_number] => 8/436730 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5080 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728915.pdf [firstpage_image] =>[orig_patent_app_number] => 436730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626199 [patent_doc_number] => 05602309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Transgenic mice which overexpress nerve growth factor' [patent_app_type] => 1 [patent_app_number] => 8/438122 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 8778 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602309.pdf [firstpage_image] =>[orig_patent_app_number] => 438122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963724 [patent_doc_number] => 05885795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Methods of expressing angiostatic protein' [patent_app_type] => 1 [patent_app_number] => 8/429743 [patent_app_country] => US [patent_app_date] => 1995-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 40 [patent_no_of_words] => 21717 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885795.pdf [firstpage_image] =>[orig_patent_app_number] => 429743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870780 [patent_doc_number] => 05747072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Adenoviral-mediated gene transfer to synovial cells in vivo' [patent_app_type] => 1 [patent_app_number] => 8/422655 [patent_app_country] => US [patent_app_date] => 1995-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 6868 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747072.pdf [firstpage_image] =>[orig_patent_app_number] => 422655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739227 [patent_doc_number] => 05698766 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Transgenic animal model for testing drugs for treating eating disorders and epilepsy' [patent_app_type] => 1 [patent_app_number] => 8/417592 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7250 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698766.pdf [firstpage_image] =>[orig_patent_app_number] => 417592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889525 [patent_doc_number] => 05750102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Double transfectants of the MHC genes as cellular vaccines for immuno prevention of tumor metastasis' [patent_app_type] => 1 [patent_app_number] => 8/412512 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 23152 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750102.pdf [firstpage_image] =>[orig_patent_app_number] => 412512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509024 [patent_doc_number] => 05587292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Diagnosis of fungal infections with a chitinase' [patent_app_type] => 1 [patent_app_number] => 8/402772 [patent_app_country] => US [patent_app_date] => 1995-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4428 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587292.pdf [firstpage_image] =>[orig_patent_app_number] => 402772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828600 [patent_doc_number] => 05814300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Gene-targeted non-human mammals deficient in the SOD-1 gene' [patent_app_type] => 1 [patent_app_number] => 8/398301 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9022 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814300.pdf [firstpage_image] =>[orig_patent_app_number] => 398301 [rel_patent_id] =>[rel_patent_doc_number] =>)